Effect of salicylates and zinc salts on leukemic cells


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription Access

Abstract

The prospects of the action of different types of chelating agents capable of binding to zinc, and salicylate ion comprising compounds on leukemic cells are reviewed. Survival rates and therapeutic indexes were compared.

About the authors

A. P. Orlov

Department of Chemistry, M. V. Lomonosov Moscow State University

Email: orlova.radiochem@mail.ru
Russian Federation, Build.3, 1 Leninskie Gory, Moscow, 119991

M. A. Orlov

Department of Chemistry, M. V. Lomonosov Moscow State University; D. Rogachev Federal Scientific Clinical Centre of Pediatric Hematology, Oncology and Immunology

Author for correspondence.
Email: orlova.radiochem@mail.ru
Russian Federation, Build.3, 1 Leninskie Gory, Moscow, 119991; 1 ul. Samory Mashela, Moscow, 119991

T. P. Trofimov

Department of Chemistry, M. V. Lomonosov Moscow State University; D. Rogachev Federal Scientific Clinical Centre of Pediatric Hematology, Oncology and Immunology

Email: orlova.radiochem@mail.ru
Russian Federation, Build.3, 1 Leninskie Gory, Moscow, 119991; 1 ul. Samory Mashela, Moscow, 119991

E. Yu. Osipova

D. Rogachev Federal Scientific Clinical Centre of Pediatric Hematology, Oncology and Immunology

Email: orlova.radiochem@mail.ru
Russian Federation, 1 ul. Samory Mashela, Moscow, 119991

A. N. Proshin

Institute of Physiologically Active Compounds, Russian Academe of Sciences

Email: orlova.radiochem@mail.ru
Russian Federation, 1 Severnyi proezd, Chernogolovka, Moscow Region, 142432

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2016 Springer Science+Business Media New York